FBYD stock surged +88% over the past 30 days, driven primarily by strong fourth-quarter 2025 earnings highlighting revenue growth in the Falcon's Creative Group segment. Over the past quarter, shares climbed +124%, reflecting a broader recovery amid small-cap market momentum and operational improvements.
RLAY stock surged +69% over the past 30 days, propelled by positive clinical data updates on its lead candidate zovegalisib. Over the past quarter, shares climbed +122%, supported by an earnings beat and advancing pipeline milestones.
CODI stock surged +72% over the last 30 days, primarily driven by the announcement of the $292.5 million sale of its Sterno food service business to reduce debt. Over the past quarter, shares climbed +88%, reflecting recovery from earlier lows amid improved subsidiary performance and strategic divestitures.
MapLight Therapeutics (MPLT) stock price rose +71% over the last 30 days amid strong analyst buy ratings and anticipation for Phase 2 clinical trial readouts. Over the past quarter, shares climbed +76%, supported by a robust cash position from its recent initial public offering (IPO) and positive regulatory designations.
HTZ stock surged +88% over the past 30 days, rising from $3.95 to $7.43, driven by strong rental demand and rising used vehicle values. Over the past quarter, shares gained +38%, recovering from a mid-period low amid positive momentum from Q4 earnings.
AMC stock surged +82% over the past 30 days, fueled by record Easter box office results and blockbuster hits like the Super Mario Bros. film.
NAK stock surged +85% over the past 30 days, driven primarily by optimism surrounding legal developments in the Pebble Project court case. Over the past quarter, shares rose +2%, reflecting volatile trading amid ongoing litigation and annual filings highlighting going-concern risks.
PAYS stock price surged +95% over the last 30 days, primarily fueled by robust fourth-quarter earnings highlighting 40% revenue growth. Over the past quarter, the stock rose +45%, supported by sustained expansion in patient affordability solutions.
ANL stock surged +116% over the past 30 days, driven primarily by a $150 million private placement equity financing announced mid-April. Over the past quarter, shares rocketed +765%, fueled by clinical trial advancements and multiple large financings amid positive analyst sentiment.
Newmont Corporation (NEM) stock rose approximately +19% over the past 30 days, driven primarily by a sharp recovery in gold prices to record highs near $5,000 per ounce. Over the past quarter, shares gained +2%, reflecting sustained gold market strength offset by rising operational costs and production disruptions.
AEM shares surged +23% over the past 30 days, propelled by a rally in gold prices amid geopolitical tensions and safe-haven demand. Over the past quarter, AEM gained +5%, reflecting volatility with a mid-period dip followed by recovery on strong operational results and higher gold realizations.
INFY rose approximately +10% over the past 30 days, driven by rallies in IT stocks, strategic AI partnerships, and positive trading in Asian ADRs. Over the past quarter, the ETF declined -21%, reflecting analyst downgrades, growth concerns, and broader IT sector pressures.
Shares of OPTX closed down approximately 17.01% on Friday, April 17, 2026, falling from a prior session close of $11.05 to approximately $9.17, extending the deep correction that accelerated following the company's late-March earnings release and cautious 2026 revenue outlook.
Shares of JLHL plunged approximately 34.16% on Friday, April 17, 2026, closing at approximately $6.40 versus a prior session close of $9.72, as speculative momentum collapsed following extraordinary recent price swings in the micro-cap stock.
Shares of LNZA collapsed approximately 37.13% on Friday, April 17, 2026, closing at approximately $22.57 versus the prior day's close of $35.90, in one of the most severe single-session selloffs for the stock on record.
Shares of OPTX are plunging approximately 16.74% in Friday's session, declining from a prior close of $11.05 to approximately $9.20, extending a sharp de-rating that began after the company's full-year 2025 results and 2026 guidance revealed consecutive quarters of expected revenue decline.
Shares of VET gapped down sharply at Friday's open, falling approximately 7% from a prior close of $12.46 to the vicinity of $11.59, as the U.S.-Iran ceasefire deal triggers a roughly 13% collapse in crude oil prices — the dominant force behind today's energy sector selloff.
OPTX stock rose +32% over the last 30 days, driven by new defense and space optics orders signaling strong demand. Over the past quarter, shares surged +146%, fueled by revenue growth, narrowed losses, and multiple contract wins in high-margin sectors.
Shares of IPI are falling approximately 9% in Friday's session, declining from a prior close of $39.22 to approximately $35.69, as the geopolitical fertilizer price premium that fueled the stock's sharp year-to-date rally rapidly deflates.
Shares of VG are falling approximately 9% in Friday's session, declining from a prior close of $12.68 to approximately $11.54, as the geopolitical LNG war premium that powered the stock's dramatic 2026 rally continues its rapid deflation.